E Fund Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.1K | Sell |
14,698
-1,295
| -8% | -$6.53K | ﹤0.01% | 381 |
|
|
2025
Q1 | $104K | Buy |
+15,993
| New | +$104K | 0.01% | 380 |
|
|
2024
Q4 | – | Sell |
-11,170
| Closed | -$83.7K | – | 414 |
|
|
2024
Q3 | $83.7K | Buy |
+11,170
| New | +$83.7K | ﹤0.01% | 344 |
|
|
2024
Q2 | – | Sell |
-20,761
| Closed | -$210K | – | 381 |
|
|
2024
Q1 | $210K | Sell |
20,761
-664
| -3% | -$6.73K | 0.01% | 337 |
|
|
2023
Q4 | $216K | Sell |
21,425
-5,557
| -21% | -$55.9K | 0.01% | 270 |
|
|
2023
Q3 | $253K | Buy |
26,982
+10,220
| +61% | +$95.8K | 0.02% | 224 |
|
|
2023
Q2 | $411K | Sell |
16,762
-319
| -2% | -$7.82K | 0.03% | 161 |
|
|
2023
Q1 | $397K | Buy |
17,081
+903
| +6% | +$21K | 0.03% | 168 |
|
|
2022
Q4 | $409K | Sell |
16,178
-5,106
| -24% | -$129K | 0.03% | 177 |
|
|
2022
Q3 | $410K | Buy |
21,284
+2,345
| +12% | +$45.2K | 0.04% | 178 |
|
|
2022
Q2 | $482K | Buy |
18,939
+6,656
| +54% | +$169K | 0.04% | 148 |
|
|
2022
Q1 | $316K | Buy |
+12,283
| New | +$316K | 0.01% | 184 |
|